Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection
- PMID: 12771723
- DOI: 10.1097/01.ju.0000066130.27119.1c
Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection
Abstract
Purpose: We better defined the benefits and morbidity of lymph node dissection in patients with localized renal cell carcinoma using the experience of patients treated at our institution.
Materials and methods: A retrospective cohort study was performed with outcome assessment based on the chart review of demographic, clinical and pathological data in 1,087 patients with renal cell carcinoma treated at our institution. Patients with renal cell carcinoma who did not undergo nephrectomy as part of cancer treatment, those with bilateral disease and those for whom nodal status was unknown were not included in this study. A total of 900 patients meeting these criteria who underwent nephrectomy for unilateral renal cell carcinoma at our medical center form the principal study population.
Results: Positive lymph nodes were associated with larger, higher grade, locally advanced primary tumors that were more commonly associated with sarcomatoid features. Positive nodes were 3 to 4 times more common in patients with metastatic disease and the majority of these patients could be identified preoperatively. The survival of patients with regional lymph node involvement only was identical to that of patients with distant metastatic disease only. Patients with regional nodes and distant metastases had significantly inferior survival to those with either condition alone. In node negative cases lymph node dissection can be performed with no additional morbidity but it confers no survival advantage. In node positive cases lymph node dissection can also be performed safely but it is associated with improved survival and a trend toward an improved response to immunotherapy.
Conclusions: Regional lymph node dissection is unnecessary in patients with clinically negative lymph nodes since it offers extremely limited staging information and no benefit in terms of decreasing disease recurrence or improving survival. In patients with positive lymph nodes lymph node dissection is associated with improved survival when it is performed in carefully selected patients undergoing cytoreductive nephrectomy and postoperative immunotherapy. When lymph nodes are present, they should be resected when technically feasible.
Similar articles
-
Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.Cancer. 2003 Jun 15;97(12):2995-3002. doi: 10.1002/cncr.11422. Cancer. 2003. PMID: 12784334
-
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.J Urol. 2001 Jul;166(1):68-72. J Urol. 2001. PMID: 11435825
-
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.J Urol. 2002 Jul;168(1):56-60. J Urol. 2002. PMID: 12050492
-
Lymph node dissection in renal cell carcinoma.Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13. Eur Urol. 2011. PMID: 21940096 Review.
-
[Renal cell carcinoma recurrence in the mediastinum lymph node 19 years after nephrectomy: a case report].Hinyokika Kiyo. 1999 Jun;45(6):419-21. Hinyokika Kiyo. 1999. PMID: 10442285 Review. Japanese.
Cited by
-
Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study.Front Oncol. 2020 Mar 19;10:365. doi: 10.3389/fonc.2020.00365. eCollection 2020. Front Oncol. 2020. PMID: 32266145 Free PMC article.
-
Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis.Asian J Urol. 2020 Jan;7(1):29-36. doi: 10.1016/j.ajur.2019.06.004. Epub 2019 Jun 29. Asian J Urol. 2020. PMID: 31970069 Free PMC article.
-
Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.Front Oncol. 2017 May 31;7:107. doi: 10.3389/fonc.2017.00107. eCollection 2017. Front Oncol. 2017. PMID: 28620578 Free PMC article. Review.
-
A Novel Preoperative Nomogram for Predicting Lymph Node Invasion in Renal Cell Carcinoma Patients Without Metastasis.Cancer Manag Res. 2019 Nov 26;11:9961-9967. doi: 10.2147/CMAR.S218254. eCollection 2019. Cancer Manag Res. 2019. PMID: 32636671 Free PMC article.
-
Feasibility of sentinel node detection in renal cell carcinoma: a pilot study.Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1117-23. doi: 10.1007/s00259-009-1359-7. Epub 2010 Jan 29. Eur J Nucl Med Mol Imaging. 2010. PMID: 20111964
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical